Finance

Beta
Lists
BNTC:NASDAQ
Benitec Biopharma Inc
$12.70
+2.67%
(+0.33) 1D
$12.70
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTC...
Open
$12.32
High
$12.74
Low
$12.04
Mkt. cap
436.30M
Avg. vol.
126.61K
Volume
98.46K
52-wk high
$16.76
52-wk low
$9.85
EPS
-$1.11
Beta
0.27
Shares outstanding
34.35M
No. of employees
19
Open
$12.32
High
$12.74
Low
$12.04
Mkt. cap
436.30M
Avg. vol.
126.61K
Volume
98.46K
52-wk high
$16.76
52-wk low
$9.85
EPS
-$1.11
Beta
0.27
Shares outstanding
34.35M
No. of employees
19
News stories
From sources across the web
About Benitec Biopharma Inc
CEO-
Employees19
Founded-
Headquarters-
SectorBiotechnology
Websitebenitec.com
Analyst ratings
Based on 5 analysts giving stock ratings to BNTC in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BNTC in the last 3 months.
Highest
Current $12.70
$32.00 (+151.97%)
Average
$25.00 (+96.85%)
Lowest
$18.00 (+41.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Hold
Downgraded
-
-
06/10/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$32.00
+152%
05/26/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$18.00
+41.7%
05/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/14/2026
Cory Kasimov
Evercore ISI
Buy
Initiated
$25.00
+96.9%
05/12/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
$22.00
+73.2%
11/04/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.70M
3.37M
5.83M
6.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.48M
6.43M
7.54M
7.28M
Operating expense
17.18M
9.80M
13.38M
13.58M
Total operating expenses
17.18M
9.80M
13.38M
13.58M
Operating income
-17.18M
-9.80M
-13.38M
-13.58M
Other non operating income
-126.00K
-84.00K
19.00K
-17.00K
EBT including unusual items
-16.15M
-8.96M
-11.84M
-11.94M
EBT excluding unusual items
-16.15M
-8.96M
-11.84M
-11.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.15M
-8.96M
-11.84M
-11.94M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.04M
1.01M
1.39M
1.59M
Interest expense
-
-
-
-
Net interest expenses
1.04M
1.01M
1.39M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.16M
-9.79M
-13.36M
-13.57M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer